All News #Library
Others
Rapid Growth of Polish Biotech Sector Leads to Demand for Foreign Expertise
31 Aug 2021 //
BUSINESSWIRE
Bioeq has submitted a BLA to the FDA for the ranibizumab biosimilar
06 Aug 2021 //
BUSINESSWIRE
Polpharma & Bioeq Joint Venture Submission of Biosimilar Ranibizu
06 Aug 2021 //
BUSINESSWIRE
Article: Polpharma’s Innovative Child is ready to harvest
24 Jul 2020 //
PRESS RELEASE
First subjects in ph III study with PB006 (proposed Biosimilar to Natalizumab) have been randomized
18 Nov 2019 //
PRESS RELEASE
Novartis strikes marketing deal for Polpharma’s potential Tysabri biosimilar
03 Sep 2019 //
PHARMAPHORUM

Market Place
Sourcing Support